NCT07299292
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07299292
Title Castration With Abiraterone 250 mg Without LHRH Analogs or Blockers in Patients With Prostate Cancer Requiring Hormonal Intensification (Multicenter Phase 2)
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors SMED Clinical Research
Indications
Therapies
Age Groups: senior | adult
Covered Countries ESP | ARG


No variant requirements are available.